Target Price | $14.75 |
Price | $12.12 |
Potential |
21.70%
register free of charge
|
Number of Estimates | 4 |
4 Analysts have issued a price target Atara Biotherapeutics Inc 2025 .
The average Atara Biotherapeutics Inc target price is $14.75.
This is
21.70%
register free of charge
$21.00
73.27%
register free of charge
$10.00
17.49%
register free of charge
|
|
A rating was issued by 5 analysts: 2 Analysts recommend Atara Biotherapeutics Inc to buy, 2 to hold and 1 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Atara Biotherapeutics Inc stock has an average upside potential 2025 of
21.70%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Million $ | 8.57 | 112.52 |
86.52% | 1,212.91% | |
EBITDA Margin | -3,085.76% | -77.78% |
654.53% | 97.48% | |
Net Margin | -4,365.61% | -7.73% |
21,484.29% | 99.82% |
5 Analysts have issued a sales forecast Atara Biotherapeutics Inc 2024 . The average Atara Biotherapeutics Inc sales estimate is
This results in the following potential growth metrics:
1 Analyst has issued an EBITDA forecast Atara Biotherapeutics Inc 2024 . The average Atara Biotherapeutics Inc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
2 Atara Biotherapeutics Inc Analysts have issued a net profit forecast 2024. The average Atara Biotherapeutics Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | -65.18 | -1.52 |
2,809.82% | 97.67% | |
P/E | negative | |
EV/Sales | 0.80 |
2 Analysts have issued a Atara Biotherapeutics Inc forecast for earnings per share. The average Atara Biotherapeutics Inc <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the Atara Biotherapeutics Inc stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Atara Biotherapeutics Inc...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.